Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant

NCT00309309 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: Rosiglitazone

Sponsor

Mario Negri Institute for Pharmacological Research